Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. DEXMETHYLPHENIDATE HYDROCHLORIDE extended-release capsules, for oral use, CIIInitial U.S. Approval: 2005
Medication labelWhy this: Advisory · dailymed-prescription
Dexmethylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14)]. Limitations of Use The use of dexmethylphenidate hydrochloride extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.7), Use in Specific Populations (8.4)].
- generic_name
- dexmethylphenidate hydrochloride
- product_names
- Dexmethylphenidate Hydrochloride
- ndc
- 0093-5550, 0093-5550-01, 0093-5551, 0093-5551-01, 0093-5552, 0093-5552-01, 0093-5553, 0093-5553-01, 0093-5045, 0093-5045-01, 0093-5554, 0093-5554-01, 0093-5046, 0093-5046-01, 0093-5562, 0093-5562-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en